Short Interest in Intuitive Surgical, Inc. (NASDAQ:ISRG) Declines By 16.6%

Intuitive Surgical, Inc. (NASDAQ:ISRG) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 3,460,000 shares, a decrease of 16.6% from the November 15th total of 4,150,000 shares. Based on an average daily volume of 1,250,000 shares, the short-interest ratio is currently 2.8 days.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Truist Financial upped their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $550.28.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of the stock. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. LGT Financial Advisors LLC lifted its position in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter valued at $33,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.9 %

Shares of ISRG stock opened at $539.58 on Monday. Intuitive Surgical has a fifty-two week low of $320.26 and a fifty-two week high of $556.23. The firm’s 50 day moving average price is $521.82 and its two-hundred day moving average price is $479.57. The stock has a market cap of $192.19 billion, a price-to-earnings ratio of 86.75, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, equities analysts forecast that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.